Skip to main content

Table 8 Meta-analyses of the efficacy of different types of treatment at follow-up regarding primary and secondary outcomes

From: The relative efficacy of bona fide psychotherapies for post-traumatic stress disorder: a meta-analytical evaluation of randomized controlled trials

Treatments

k

Hedges’ g

p

Q

p

I 2

First follow-up

 Cognitive behavior therapy (all)

14

0.01 [−0.17, 0.20]

.906

24.64

.026

49 % (5–71 %)

  

−0.02 [−0.16, 0.12]

.739

20.95

.074

28 % (0–66 %)

 Trauma focused cognitive behavior therapy with exposure (subgroup)

9

0.13 [0.00, 0.26]

.053

14.88

.062

0 % (0–93 %)

  

0.07 [−0.12, 0.25]

.483

14.67

.066

40 % (40–93 %)

 Exposure

7

−0.04 [−0.25, 0.17]

.705

2.88

.824

0 % (0–40 %)

  

−0.06 [−0.25, 0.13]

.506

5.96

.428

0 % (0–71 %)

 Prolonged exposure

7

0.10 [−0.14, 0.34]

.406

9.43

.151

39 % (0–70 %)

  

0.18 [−0.12, 0.47]

.240

14.06

.029

62 % (7–80 %)

 Exposure + prolonged exposure

14

0.04 [−0.11, 0.20]

.575

13.67

.398

20 % (0–57 %)

  

0.06 [−0.11, 0.22]

.515

21.89

.057

39 % (0–67 %)

 EMDR

5

−0.02 [−0.62, 0.57]

.940

13.32

.010

72 % (28–87 %)

  

−0.05 [−0.66, 0.56]

.874

13.65

.009

73 % (17–84 %)

 Present-centered therapies

6

−0.17 [−0.30, −0.04]

.010

3.71

.592

0 % (0–67 %)

  

−0.05 [−0.18, 0.09]

.477

7.26

.202

13 % (0–67 %)

 TF vs. NTF

9

0.17 [0.05, 0.28]

.006

4.05

.852

0 % (0–67 %)

  

0.05 [−0.07, 0.18]

.401

11.70

.165

18 % (18–94 %)

Second follow-up

 Cognitive behavior therapy (all)

8

0.02 [−0.40, 0.44]

.926

25.14

.001

80 % (44–86 %)

  

−0.06 [−0.37, 0.24]

.680

23.12

.002

72 % (39–85 %)

 Trauma focused cognitive behavior therapy with exposure (subgroup)

5

0.30 [−0.03, 0.63]

.076

7.95

.093

52 % (52–96 %)

  

0.16 [−0.11, 0.43]

.234

8.69

.070

52 % (52–94 %)

 TF vs. NTF

6

0.23 [0.01, 0.46]

.045

8.20

.146

28 % (28–95 %)

  

0.05 [−0.08, 0.18]

.466

5.35

.374

0 % (0–92 %)

  1. Note. k = number of comparisons; Q = statistic of effect size heterogeneity. Values of Hedges’ g and I 2 are presented alongside their 95 % confidence intervals. Hedges’ g > 0 signifies a higher efficacy for the type of treatment of interest compared to all other available treatments, Hedges’ g < 0 signifies a lower efficacy. Per type of treatment, values in the first line pertain to primary outcomes (i.e., PTSD symptom severity), values in the second line to secondary outcomes (i.e., symptom severity of comorbid disorders, trauma-related symptoms, general symptom distress, social functioning, and quality of life)